Catheter Precision, Inc. announced on May 12, 2025, that it entered into securities purchase agreements with institutional investors for a $1.5 million private placement equity financing. This transaction provides immediate financial resources for the company.
In exchange for $1.5 million in cash, the company sold 1,500 shares of its Series B Preferred Stock, convertible into an aggregate of 4,287,000 shares of common stock, and 4,285,716 Warrants to purchase common stock at an exercise price of $0.50 per share. The majority of the Preferred Stock and all Warrants require shareholder approval for conversion.
The company also issued an additional 1,500 shares of Series B Preferred Stock to acquire preexisting senior secured notes of QHSLab, Inc., with an approximate principal amount of $1.6 million. These QHSLab notes are currently in default, and their valuation is uncertain, introducing risk to the transaction. The company and QHS are pursuing a strategic partnership within the cardiovascular space.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.